Common use of Principal Amount; Series Treatment Clause in Contracts

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000[____________]. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall initially be initially limited to an aggregate principal amount of $500,000,000300,000,000 (the “Initial Notes”). The Company may, from time to time, time without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Debt Securities under the Indenture Indenture, as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes or additional Notes, shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Companyconstitute one series of Debt Securities and shall vote together as one series of Debt Securities. (b) Any additional Notes issued under Section 2.02(a2.2(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding outstanding Notes of such series from the first date that the Outstanding outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued only in fully registered form, without coupons, and only in minimum denominations of $2,000 1,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000250,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Securities under the Indenture Indenture, as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall initially be initially limited to an aggregate principal amount of $500,000,000350,000,000 (the “Initial Notes”). The Company may, from time to time, time without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Debt Securities under the Indenture Indenture, as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes or additional Notes, shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Companyconstitute one series of Debt Securities and shall vote together as one series of Debt Securities. (b) Any additional Notes issued under Section 2.02(a2.2(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding outstanding Notes of such series from the first date that the Outstanding outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued only in fully registered form, without coupons, and only in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall will be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding outstanding Notes of such series from the first date that the Outstanding outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000350,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, Exchange Notes or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 100,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $€500,000,000; except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of, Notes pursuant to Sections 203, 304, 305, 306 or 906 of the Base Indenture. The However, the Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding other Outstanding Notes of this series shall be consolidated together and form a single series of Securities under the Indenture Indenture, as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Outstanding Notes of such series (other than the additional Notes) or or, if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, Notes or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000650,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall will be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the such additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the such additional Notes) or if no interest has been paid on the Outstanding outstanding Notes of such series from the first date that the Outstanding such outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture; provided that, if such additional Notes are not fungible with the Initial Notes for U.S. Federal income tax purposes, such additional Notes shall have a separate CUSIP number. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a)) or Exchange Notes, shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes shall be initially limited to an aggregate principal amount of $500,000,000€600,000,000. The Company may, from time to time, without the consent of the Holders of the outstanding Notes, issue additional Notes, so that such additional Notes and the outstanding Notes shall will be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding outstanding Notes of such series from the first date that the Outstanding outstanding Notes were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all Notes, whether Initial Notes, or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 €100,000 and in integral multiples of $€1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The 2025 Notes shall be initially limited to an aggregate principal amount of $500,000,000, and the 2045 Notes shall be initially limited to an aggregate principal amount of $500,000,000. The However, the Company may, from time to time, without the consent of the Holders of the outstanding NotesNotes of either series, issue additional NotesNotes of any series, so that such additional Notes and the outstanding Notes of such series shall be consolidated together and form a single series of Securities under the Indenture Indenture, as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the Outstanding Notes of such series (other than the additional Notes) or or, if no interest has been paid on the Outstanding Notes of such series from the first date that the Outstanding Notes of such series were originally issued under the Indenture, as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this Supplemental Indenture, all NotesNotes of the same series, whether Initial Notes, Notes or additional Notes issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.

Principal Amount; Series Treatment. (a) The Notes due 2015 shall be initially limited to an aggregate principal amount of $500,000,000600,000,000. The Company may, from time without notice to time, without or the consent of the Holders of the outstanding NotesNotes due 2015, issue additional NotesNotes due 2015 by Company Order, so that such additional Notes notes and the outstanding Notes due 2015 shall be consolidated together and form a single series of Securities under the Indenture as supplemented by this Supplemental Indenture. Any increase in the aggregate principal amount of the Notes shall be evidenced by an Officers’ Certificate to be delivered to the Trustee, without any further action by the Company. (b) Any additional Notes issued under Section 2.02(a) shall have the same terms in all respects as the corresponding series of outstanding Notes, except that interest will accrue on the additional Notes from the most recent date to which interest has been paid on the corresponding series of Notes of such series (other than the additional Notes) or if no interest has been paid on the Outstanding corresponding series of Notes of such series from the first date that the Outstanding corresponding series of Notes were was originally issued under the Indenture, Indenture as supplemented by this Supplemental Indenture. (c) For all purposes of the Indenture and this the Supplemental Indenture, all NotesNotes due 2015, whether Initial Notes, Exchange Notes or additional Notes due 2015 issued under Section 2.02(a), shall constitute one series of Securities and shall vote together as one series of Securities. (d) The Notes shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.